A normal glucose result can be reassuring, but it does not always rule out a developing metabolic problem. The most useful markers of insulin resistance can show that the body is producing extra insulin to keep blood glucose within range - often years before glucose alone becomes clearly abnormal.
Insulin resistance is not a diagnosis made from one number in isolation. It is a pattern: glucose regulation, insulin output, blood fats, body composition, symptoms and medical history all provide context. Testing can offer a more precise starting point for people concerned about energy crashes, increased waist circumference, cravings, polycystic ovary syndrome (PCOS), fertility, family history of type 2 diabetes or cardiometabolic risk.
What insulin resistance means
Insulin is a hormone made by the pancreas. Its role includes helping glucose move from the bloodstream into muscle, liver and fat cells, where it can be used or stored. When cells respond less effectively to insulin, the pancreas may compensate by releasing more of it.
At first, this compensation can keep fasting glucose and HbA1c in the reference range. That is why fasting insulin and calculated insulin-resistance scores can add useful detail. Over time, if the pancreas can no longer keep pace, glucose may rise into the prediabetes or diabetes range.
Insulin resistance is influenced by several factors. Genetics, abdominal fat distribution, sleep disruption, low activity, some medicines, menopause, PCOS, fatty liver disease and chronic stress can all contribute. It is not simply a reflection of willpower or a single food choice.
The key markers of insulin resistance
Fasting insulin
Fasting insulin is often the most informative early marker. A raised fasting insulin result may indicate that the pancreas is working harder than usual to maintain glucose control. It can therefore identify compensatory hyperinsulinaemia before fasting glucose becomes elevated.
Results need careful interpretation. Insulin concentrations vary with fasting duration, recent illness, exercise, alcohol intake and laboratory method. A single result cannot confirm the cause of a raised level, but paired with fasting glucose it provides a stronger picture than either marker on its own.
For accurate assessment, follow the collection instructions closely. A true overnight fast is usually required for fasting insulin testing. Do not make major changes to diet, supplements or exercise immediately beforehand unless advised by your clinician.
Fasting glucose
Fasting glucose measures the level of glucose circulating in the blood after fasting. It remains a valuable marker, particularly when results are raised. However, it is relatively late to change in some people with insulin resistance because increased insulin output can temporarily keep glucose controlled.
A fasting glucose result should not be dismissed when it falls within range, nor should it be overinterpreted without insulin. The clinical value lies in understanding the relationship between the two.
HOMA-IR
HOMA-IR, short for Homeostatic Model Assessment of Insulin Resistance, is a calculated score based on fasting insulin and fasting glucose. It estimates how much insulin is required to maintain fasting glucose levels.
This score is widely used in research and clinical settings because it converts two related results into a practical measure of insulin resistance. There is no single universal cut-off that applies to every laboratory, population or clinical situation. Reference ranges, units, ethnicity, age, body composition and health history all matter. The trend over time can be particularly useful when testing is repeated under comparable conditions.
HbA1c
HbA1c reflects average blood glucose exposure over approximately the previous two to three months. It is a recognised marker used to assess prediabetes and diabetes risk, and it can be helpful where day-to-day glucose readings do not tell the whole story.
Its limitation is timing. HbA1c may remain normal during the earlier, high-insulin stage of insulin resistance. It can also be affected by conditions that alter red blood cell turnover, including some forms of anaemia, recent blood loss and certain haemoglobin variants. It is best viewed alongside fasting insulin and glucose rather than as a standalone metabolic health test.
Triglycerides and HDL cholesterol
Insulin resistance commonly affects lipid metabolism. Raised triglycerides and lower HDL cholesterol can form part of the metabolic pattern, particularly alongside increased waist circumference or raised blood pressure.
The triglyceride-to-HDL ratio is sometimes used as a simple supporting indicator of insulin resistance. It is not a replacement for direct insulin testing, and lipid results may be influenced by genetics, alcohol, thyroid function, diet and medication. Still, a full lipid profile adds valuable cardiometabolic context.
Liver enzymes and fatty liver risk
The liver plays a central role in glucose and insulin regulation. When liver cells become less responsive to insulin, the liver may continue releasing glucose even when the body does not need it. Insulin resistance is also closely associated with metabolic dysfunction-associated steatotic liver disease, previously often called fatty liver disease.
Alanine aminotransferase (ALT), gamma-glutamyl transferase (GGT) and other liver markers may be included in broader health assessments. Normal liver enzymes do not exclude fatty liver, but raised results deserve clinical follow-up, especially when fasting insulin, triglycerides or waist circumference are also elevated.
Symptoms that can justify a closer look
Insulin resistance can be present without obvious symptoms. When symptoms do occur, they are often non-specific: persistent fatigue, hunger soon after meals, afternoon energy dips, difficulty managing weight, increased central weight gain or strong cravings for carbohydrate-rich foods.
Some signs provide a clearer reason to test. These include acanthosis nigricans - darkened, velvety skin often found around the neck, underarms or groin - as well as skin tags. In women, irregular cycles, acne, excess facial hair or known PCOS may warrant assessment because insulin resistance is common in PCOS, though not universal. In men, low energy, increasing abdominal fat and low testosterone symptoms can overlap with metabolic concerns, but hormone testing and clinical context are needed to distinguish possible causes.
Why one marker is rarely enough
A fasting insulin result can be high with normal glucose. HbA1c can be borderline while fasting insulin appears unremarkable. Triglycerides may rise due to alcohol intake or genetics rather than insulin resistance alone. These are not contradictions - they show why isolated testing has limits.
A clinically useful assessment usually combines fasting insulin, fasting glucose and HOMA-IR, then considers HbA1c and a lipid profile. Depending on symptoms, it may also be sensible to assess thyroid function, sex hormones, cortisol patterns or liver markers. For example, untreated hypothyroidism can adversely affect cholesterol and weight, while PCOS assessment often benefits from a broader hormone profile rather than insulin testing alone.
This is where laboratory accuracy and appropriate interpretation matter. Results should be compared with the laboratory reference intervals and considered alongside current medication, pregnancy status, diagnosed health conditions and family history.
When to speak to a clinician
Seek medical advice promptly if testing suggests diabetes-range glucose results, if you are pregnant or planning pregnancy with abnormal glucose markers, or if you have symptoms such as excessive thirst, frequent urination, unexplained weight loss or blurred vision. These require timely clinical assessment rather than self-management.
It is also sensible to discuss persistently raised insulin, HOMA-IR, HbA1c, triglycerides or liver enzymes with a GP or qualified healthcare professional. They can assess blood pressure, waist circumference, medication effects and wider risk, then advise whether further investigation or treatment is appropriate.
For those looking for detailed, convenient metabolic insight, a professionally analysed at-home fasting insulin test can provide a useful starting point. Hormone Lab UK testing is designed to help turn concerns about symptoms and risk factors into measurable information - but meaningful next steps always come from reading the whole pattern, not chasing a perfect number.